AU2005229437A1 - Filamentous fungal mutants with improved homologous recombination efficiency - Google Patents

Filamentous fungal mutants with improved homologous recombination efficiency Download PDF

Info

Publication number
AU2005229437A1
AU2005229437A1 AU2005229437A AU2005229437A AU2005229437A1 AU 2005229437 A1 AU2005229437 A1 AU 2005229437A1 AU 2005229437 A AU2005229437 A AU 2005229437A AU 2005229437 A AU2005229437 A AU 2005229437A AU 2005229437 A1 AU2005229437 A1 AU 2005229437A1
Authority
AU
Australia
Prior art keywords
gene
nhr
mutant
dna
filamentous fungus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005229437A
Other languages
English (en)
Inventor
Van Den Marco Alexander Berg
Petrus Jacobus Theodorus Dekker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DSM IP Assets BV
Original Assignee
DSM IP Assets BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34966505&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2005229437(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by DSM IP Assets BV filed Critical DSM IP Assets BV
Publication of AU2005229437A1 publication Critical patent/AU2005229437A1/en
Priority to AU2012211485A priority Critical patent/AU2012211485A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/38—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from Aspergillus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/385—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from Penicillium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P23/00—Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P37/00—Preparation of compounds having a 4-thia-1-azabicyclo [3.2.0] heptane ring system, e.g. penicillin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/80—Penicillium
    • C12R2001/82—Penicillium chrysogenum

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Mushroom Cultivation (AREA)
AU2005229437A 2004-04-02 2005-03-31 Filamentous fungal mutants with improved homologous recombination efficiency Abandoned AU2005229437A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2012211485A AU2012211485A1 (en) 2004-04-02 2012-08-10 Filamentous fungal mutants with improved homologous recombination efficiency

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04076057 2004-04-02
EP04076057.1 2004-04-02
PCT/EP2005/051464 WO2005095624A2 (fr) 2004-04-02 2005-03-31 Mutants fongiques filamenteux avec meilleure efficacite de recombinaison homologue

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2012211485A Division AU2012211485A1 (en) 2004-04-02 2012-08-10 Filamentous fungal mutants with improved homologous recombination efficiency

Publications (1)

Publication Number Publication Date
AU2005229437A1 true AU2005229437A1 (en) 2005-10-13

Family

ID=34966505

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005229437A Abandoned AU2005229437A1 (en) 2004-04-02 2005-03-31 Filamentous fungal mutants with improved homologous recombination efficiency

Country Status (12)

Country Link
US (2) US9243043B2 (fr)
EP (3) EP1733040B1 (fr)
JP (2) JP2007530065A (fr)
CN (1) CN101218348B (fr)
AT (1) ATE480632T1 (fr)
AU (1) AU2005229437A1 (fr)
CA (1) CA2559827A1 (fr)
DE (1) DE602005023427D1 (fr)
DK (1) DK1733040T3 (fr)
ES (1) ES2350048T3 (fr)
PL (1) PL1733040T3 (fr)
WO (1) WO2005095624A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109790510A (zh) * 2016-10-04 2019-05-21 丹尼斯科美国公司 在不存在诱导底物下丝状真菌细胞中的蛋白产生

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2383366T3 (es) * 2003-06-25 2012-06-20 Novozymes A/S Enzimas para el tratamiento de almidón
DE602005023427D1 (de) 2004-04-02 2010-10-21 Dsm Ip Assets Bv Filamentöse pilzmutanten mit verbesserter homologer rekombinationseffizienz
JP4625318B2 (ja) * 2004-12-06 2011-02-02 財団法人野田産業科学研究所 相同組換え頻度が上昇した形質転換菌
US7888489B2 (en) 2005-01-24 2011-02-15 Dsm Ip Assets B.V. Method for producing a compound of interest in a filamentous fungal cell
US20080227148A1 (en) * 2005-03-01 2008-09-18 Thibaut Jose Wenzel Aspergillus Promotors for Expressing a Gene in a Fungal Cell
EP1954812B1 (fr) 2005-11-29 2012-11-21 DSM IP Assets B.V. Site de liaison a l'adn d'un activateur transcriptionnel utile dans l'expression genetique
CN101400694B (zh) 2005-12-01 2013-07-24 阿德库端木营养控股有限责任公司 用于工业生产柠檬酸的基因
JP5250850B2 (ja) 2006-06-29 2013-07-31 ディーエスエム アイピー アセッツ ビー．ブイ． 改善されたポリペプチド発現を達成する方法
EP2082046A2 (fr) 2006-11-02 2009-07-29 DSMIP Assets B.V. Production améliorée de protéines sécrétées par des champignons filamenteux
CN101784666A (zh) 2007-02-15 2010-07-21 帝斯曼知识产权资产管理有限公司 用于生产感兴趣的化合物的重组宿主细胞
DK2126100T3 (da) 2007-03-21 2013-01-14 Dsm Ip Assets Bv Forbedret fremgangsmåde til homolog rekombination
WO2008138835A1 (fr) 2007-05-09 2008-11-20 Novozymes A/S Procédé de clonage d'expression, approprié pour sélectionner des clones de bibliothèque produisant un polypeptide d'intérêt
EP2123772A1 (fr) 2008-04-29 2009-11-25 DSM IP Assets B.V. Souches produisant des antibiotiques bêta-lactamines
EP2392649A3 (fr) 2008-08-05 2012-01-11 DSM IP Assets B.V. Adipoyl-7-ADCA produisant des souches
WO2010102976A1 (fr) 2009-03-10 2010-09-16 Dsm Ip Assets B.V. Estérase prégastrique et ses dérivés
EP2406386B1 (fr) 2009-03-10 2019-01-23 DSM IP Assets B.V. Procede pour augmenter la production d'une proteine
CN102348805A (zh) 2009-03-11 2012-02-08 帝斯曼知识产权资产管理有限公司 己二酸的制备
US20120041171A1 (en) 2009-04-22 2012-02-16 Dsm Ip Assets B.V. Process for the production of a recombinant polypeptide of interest
BRPI1015536A2 (pt) 2009-04-24 2019-07-02 Dsm Ip Assets Bv polipeptídeo de degradação de carboidratos e usos do mesmo
CA2768608A1 (fr) 2009-07-22 2011-01-27 Dsm Ip Assets B.V. Cellule hote amelioree destinee a la production d'un compose interessant
WO2011054899A1 (fr) 2009-11-04 2011-05-12 Dsm Ip Assets B.V. Transformants de talaromyces
EP2531590A2 (fr) 2010-02-04 2012-12-12 DSM IP Assets B.V. Procédé pour la préparation de souches fongiques filamenteuses ayant un cycle sexuel et procédé pour la préparation de souches fongiques filamenteuses à croisement sexuel
AU2011214324B2 (en) 2010-02-11 2014-11-20 Dsm Ip Assets B.V. Host cell capable of producing enzymes useful for degradation of lignocellulosic material
EA201201126A1 (ru) 2010-02-11 2013-05-30 ДСМ АйПи АССЕТС Б.В. Полипептид, обладающий активностью целлобиогидролазы, и его применение
CA2801824A1 (fr) 2010-06-29 2012-01-05 Dsm Ip Assets B.V. Polypeptide dote d'une activite de swollenine et ses utilisations
CN103119156A (zh) 2010-06-29 2013-05-22 帝斯曼知识产权资产管理有限公司 具有降解碳水化合物活性的多肽及其用途
MX2012015144A (es) 2010-06-29 2013-03-05 Dsm Ip Assets Bv Polipeptido que tiene actividad de acetil-xilan-esterasa y usos del mismo.
PL2588494T3 (pl) 2010-06-29 2018-08-31 Dsm Ip Assets B.V. Polipeptyd mający aktywność beta-glukozydazy i jego zastosowania
CA2803986C (fr) 2010-06-29 2019-04-23 Dsm Ip Assets B.V. Polypeptide presentant une activite de degradation de glucides ou facilitant cette activite, et ses applications
CN102971338A (zh) 2010-06-29 2013-03-13 帝斯曼知识产权资产管理有限公司 具有β-葡糖苷酶活性的多肽及其用途
US8945898B2 (en) 2010-07-01 2015-02-03 Dsm Ip Assets B.V. Recombinant host cell with deficiency in non-ribosomal peptide synthase production
WO2012031910A2 (fr) 2010-09-10 2012-03-15 Dsm Ip Assets B.V. Procédé de préparation d'acide alpha-cétopimélique par élongation c1
WO2012123429A1 (fr) 2011-03-11 2012-09-20 Dsm Ip Assets B.V. Système vecteur-hôte
WO2013076280A1 (fr) 2011-11-23 2013-05-30 Dsm Ip Assets B.V. Système d'assemblage d'acides nucléiques
BR112014031526A2 (pt) 2012-06-19 2017-08-01 Dsm Ip Assets Bv promotores para expressar um gene em uma célula
EP2875119B1 (fr) 2012-07-19 2017-12-20 DSM IP Assets B.V. Souche déficiente en agse
RU2015115890A (ru) * 2012-09-28 2016-11-20 Юсб Биофарма Спрл Способы получения рекомбинантных белков
PL3686280T3 (pl) 2013-02-04 2022-09-19 Dsm Ip Assets B.V. Polipeptyd degradujący węglowodany i jego zastosowania
WO2014142647A1 (fr) 2013-03-14 2014-09-18 Wageningen Universiteit Souches fongiques ayant une production améliorée d'acide citrique et d'acide itaconique
WO2014202622A2 (fr) 2013-06-19 2014-12-24 Dsm Ip Assets B.V. Gène de rasamsonia et son utilisation
WO2014202624A2 (fr) 2013-06-19 2014-12-24 Dsm Ip Assets B.V. Gène de rasamsonia et son utilisation
WO2014202620A2 (fr) 2013-06-19 2014-12-24 Dsm Ip Assets B.V. Gène de rasamsonia et son utilisation
WO2014202621A1 (fr) 2013-06-20 2014-12-24 Dsm Ip Assets B.V. Polypeptide de dégradation des hydrates de carbone et utilisations de ce dernier
EP3077517B1 (fr) 2013-12-02 2018-10-17 DSM IP Assets B.V. Protéine de structuration de glace
US20160312233A1 (en) * 2013-12-13 2016-10-27 Cellectis New method of selection of algal-transformed cells using nuclease
EP3242949B1 (fr) 2015-01-06 2021-11-03 DSM IP Assets B.V. Système crispr-cas destiné à une cellule hôte de lévure
EP3242950B1 (fr) 2015-01-06 2021-10-06 DSM IP Assets B.V. Système crispr-cas destiné à une cellule hôte de lévure
EP3302076A1 (fr) 2015-06-02 2018-04-11 DSM IP Assets B.V. Utilisation de la protéine structurante de la glace afp19 exprimée dans des souches fongiques filamenteuses pour la préparation de produits alimentaires
US20180362961A1 (en) * 2015-12-11 2018-12-20 Danisco Us Inc. Methods and compositions for enhanced nuclease-mediated genome modification and reduced off-target site effects
US10913938B2 (en) 2016-07-29 2021-02-09 Dsm Ip Assets B.V. Polypeptides having cellulolytic enhancing activity and uses thereof
WO2018114912A1 (fr) 2016-12-21 2018-06-28 Dsm Ip Assets B.V. Variants d'enzyme lipolytique
WO2018114938A1 (fr) 2016-12-21 2018-06-28 Dsm Ip Assets B.V. Variants d'enzyme lipolytique
EP3559222A1 (fr) 2016-12-21 2019-10-30 DSM IP Assets B.V. Variants d'enzyme lipolytique
CA3046153A1 (fr) 2016-12-21 2018-06-28 Dsm Ip Assets B.V. Variants d'enzyme lipolytique
US20200063166A1 (en) 2017-03-13 2020-02-27 Dsm Ip Assets B.V. Zinc binuclear cluster transcriptional regulator-deficient strain
WO2018226900A2 (fr) 2017-06-06 2018-12-13 Zymergen Inc. Plate-forme d'ingénierie génomique htp permettant d'améliorer les souches fongiques
WO2019236848A1 (fr) 2018-06-06 2019-12-12 Zymergen Inc. Manipulation de gènes impliqués dans la transduction de signal pour réguler la morphologie fongique pendant la fermentation et la production
US20220389458A1 (en) 2019-11-04 2022-12-08 Dsm Ip Assets B.V. Low volume transfection
CN111088173B (zh) * 2019-12-26 2021-08-20 南京高新工大生物技术研究院有限公司 一株黑曲霉基因工程菌及其构建方法和应用
CN113106126B (zh) * 2020-01-09 2023-07-18 中国科学院分子植物科学卓越创新中心 一种提高真菌的原生质体转化效率或基因编辑效率的方法及试剂盒
US11479779B2 (en) 2020-07-31 2022-10-25 Zymergen Inc. Systems and methods for high-throughput automated strain generation for non-sporulating fungi
EP4019627A1 (fr) 2020-12-28 2022-06-29 Koninklijke Nederlandse Akademie van Wetenschappen Nouvelles enzymes et procédés pour des voies métaboliques associées à l'acide benzoïque
EP4032900A1 (fr) 2021-01-21 2022-07-27 Koninklijke Nederlandse Akademie van Wetenschappen Nouvelles enzymes et procédés pour des voies métaboliques associées à l'acide vanillique
WO2023222614A1 (fr) 2022-05-16 2023-11-23 Dsm Ip Assets B.V. Variants d'enzymes lipolytiques

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8416212D0 (en) 1984-06-26 1984-08-01 Sturge John & E Ltd Lactase containing compositions
CA1341226C (fr) 1988-08-16 2001-05-01 Wim Van Hartingsveldt Replacement de gene comme outil de construction de souches d'aspergillus
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
EP0635574B1 (fr) 1993-07-23 2003-04-23 Dsm N.V. Souches récombinantes dépourvues de marqueurs de sélection: procédé pour leur obtention et utilisation de ces souches
ATE418614T1 (de) 1995-08-03 2009-01-15 Dsm Ip Assets Bv Amds-gen aus aspergillus niger für eine acetamidase kodierend
DK0979294T3 (en) 1997-04-11 2015-08-31 Dsm Ip Assets Bv Gene conversion AS A TOOL FOR CONSTRUCTION OF RECOMBINANT INDUSTRIAL filamentous fungi
EP1071471B1 (fr) 1998-04-15 2008-12-31 Fred Hutchinson Cancer Research Center Procedes et constructions vectorielles pour produire des rongeurs transgeniques exprimant de maniere ubiquitaire un gene heterologue
GB9907687D0 (en) 1999-04-01 1999-05-26 Kudos Pharm Ltd Assays methods and means
WO2001042442A2 (fr) 1999-12-10 2001-06-14 Cytos Biotechnology Ag Activation de genes endogenes basee sur un replicon
US6569681B1 (en) * 2000-03-14 2003-05-27 Transkaryotic Therapies, Inc. Methods of improving homologous recombination
KR20030085112A (ko) 2000-12-07 2003-11-03 디에스엠 아이피 어셋츠 비.브이. 카르복시 말단 프롤린 잔기를 갖는 펩티드가 풍부한단백질 가수분해물
EP1217074A1 (fr) 2000-12-22 2002-06-26 Universiteit Leiden Intégration d'ADN dans des eukaryotes
WO2002079476A1 (fr) * 2001-03-30 2002-10-10 National Institute Of Advanced Industrial Science And Technology Methode de detection de l'expression du gene d'aspergillus
DE10131786A1 (de) 2001-07-04 2003-01-16 Sungene Gmbh & Co Kgaa Rekombinationssysteme und Verfahren zum Entfernen von Nukleinsäuresequenzen aus dem Genom eukaryotischer Organismen
US20030092183A1 (en) 2001-09-21 2003-05-15 Fisher Katherine E. Rapid creation of gene targeting vectors using homologous recombination in yeast
WO2003089617A2 (fr) 2002-04-22 2003-10-30 Novozymes Biotech, Inc. Methodes pour augmenter la recombinaison homologue d'une sequence d'acide nucleique
EP1673380A2 (fr) 2003-10-14 2006-06-28 DSM IP Assets B.V. Procede de production de cellules hotes modifiees
CA2548220A1 (fr) 2003-12-01 2005-09-09 Introgen Therapeutics, Inc. Utilisation de mda-7 pour inhiber des organismes infectieux pathogenes
US20050181509A1 (en) 2004-02-12 2005-08-18 The Penn State Research Foundation Dual selection based, targeted gene disruption method for fungi and fungus-like organisms
JP4050712B2 (ja) * 2004-02-27 2008-02-20 独立行政法人科学技術振興機構 相同組換えを行わせる方法
DE602005023427D1 (de) 2004-04-02 2010-10-21 Dsm Ip Assets Bv Filamentöse pilzmutanten mit verbesserter homologer rekombinationseffizienz
JP2006058093A (ja) * 2004-08-18 2006-03-02 National Institute For Materials Science 血液分析装置
AU2005287547B2 (en) 2004-09-23 2010-09-02 Basf Plant Science Gmbh Recombination cassettes and methods for sequence excision in plants
WO2007013979A2 (fr) 2005-07-20 2007-02-01 Invitrogen Corporation Methodes pouvant augmenter l'efficience d'une recombinaison homologue
DE602007012846D1 (de) 2006-04-08 2011-04-14 Dsm Ip Assets Bv Verbessertes verfahren zur homologen rekombination in eukaryontischen zellen
DK2126100T3 (da) 2007-03-21 2013-01-14 Dsm Ip Assets Bv Forbedret fremgangsmåde til homolog rekombination
US8597923B2 (en) 2009-05-06 2013-12-03 SyntheZyme, LLC Oxidation of compounds using genetically modified Candida

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109790510A (zh) * 2016-10-04 2019-05-21 丹尼斯科美国公司 在不存在诱导底物下丝状真菌细胞中的蛋白产生
CN109790510B (zh) * 2016-10-04 2024-04-12 丹尼斯科美国公司 在不存在诱导底物下丝状真菌细胞中的蛋白产生

Also Published As

Publication number Publication date
US20080227145A1 (en) 2008-09-18
EP2172557B1 (fr) 2018-03-14
US20160130589A1 (en) 2016-05-12
EP2172557A8 (fr) 2010-06-23
ATE480632T1 (de) 2010-09-15
DE602005023427D1 (de) 2010-10-21
US9657301B2 (en) 2017-05-23
US9243043B2 (en) 2016-01-26
PL1733040T3 (pl) 2011-01-31
DK1733040T3 (da) 2010-11-22
JP2007530065A (ja) 2007-11-01
EP3351637B1 (fr) 2020-06-10
CN101218348A (zh) 2008-07-09
EP3351637A1 (fr) 2018-07-25
EP1733040B1 (fr) 2010-09-08
CN101218348B (zh) 2014-07-30
CA2559827A1 (fr) 2005-10-13
ES2350048T3 (es) 2011-01-17
EP2172557A1 (fr) 2010-04-07
WO2005095624A2 (fr) 2005-10-13
EP1733040A2 (fr) 2006-12-20
JP2011152148A (ja) 2011-08-11
WO2005095624A3 (fr) 2006-02-16

Similar Documents

Publication Publication Date Title
US9657301B2 (en) Filamentous fungal mutants with improved homologous recombination efficiency
US8642290B2 (en) Fungal transcriptional activators useful in methods for producing a polypeptide
AU2005254734B9 (en) Production of polypeptides by improved secretion
EP1954812B1 (fr) Site de liaison a l'adn d'un activateur transcriptionnel utile dans l'expression genetique
Riach et al. Genetic transformation and vector developments in filamentous fungi
EP2456872A1 (fr) Cellule hôte améliorée destinée à la production d'un composé intéressant
WO2006092396A1 (fr) Promoteurs d'aspergillus utiles pour l'expression d'un gene dans une cellule fongique
Bloemendal et al. Tools for advanced and targeted genetic manipulation of the β-lactam antibiotic producer Acremonium chrysogenum
CN105492604B (zh) 受调节的pepc表达
AU2005293516B2 (en) Homologous amdS genes as selectable marker
US20130189733A1 (en) Production of secreted proteins by filamentous fungi
US20220235378A1 (en) Multipartite crispr donor
AU2012211485A1 (en) Filamentous fungal mutants with improved homologous recombination efficiency

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted